Sign in

CIK 0001690585

  • Non-accelerated filer
  • Smaller reporting company

Dianthus Therapeutics, Inc. /DE/

Sign in to watch
Ticker
DNTH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 929-999-4055
Business address
7 TIMES SQUARE, 43RD FLOOR, NEW YORK, NY, 10036
Former names
Magenta Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$15,717,056
in 3 filings, $15.7M under 10b5-1 plans

Net −$15,717,056. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-09 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −15,329 $101.24 $1.6M 5,566
2026-07-09 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −5,566 $101.97 $568K 0
2026-06-17 Veness Adam M SVP, General Counsel and Sec. Sale 10b5-1 −16,771 $80.34 $1.3M 13,229
2026-06-17 Veness Adam M SVP, General Counsel and Sec. Sale 10b5-1 −13,229 $81.38 $1.1M 0
2026-06-01 Randhawa Simrat EVP, Head of R&D Sale 10b5-1 −5,428 $89.72 $487K 25,102
2026-06-01 Randhawa Simrat EVP, Head of R&D Sale 10b5-1 −16,943 $90.72 $1.5M 8,159
2026-06-01 Randhawa Simrat EVP, Head of R&D Sale 10b5-1 −4,159 $91.37 $380K 4,000
2026-05-08 Soteropoulos Paula Director Sale 10b5-1 −599 $85.47 $51K 0
2026-04-09 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −8,224 $89.84 $739K 0
2026-03-31 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −1,390 $78.33 $109K 112,977
2026-03-31 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −21,825 $78.86 $1.7M 91,152
2026-03-31 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −1,485 $80.25 $119K 89,667
2026-03-31 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −800 $81.36 $65K 88,867
2026-03-31 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −2,366 $82.84 $196K 86,501
2026-03-31 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −59,800 $83.90 $5.0M 26,701
2026-03-31 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −19,469 $84.57 $1.6M 7,232
2026-03-31 Savitz Ryan EVP, CFO & CBO Sale 10b5-1 −7,232 $85.54 $619K 0
2026-03-31 Soteropoulos Paula Director Sale 10b5-1 −599 $80.11 $48K 0
2026-03-24 Soteropoulos Paula Director Sale 10b5-1 −27,594 $78.05 $2.2M 0
2026-03-12 Randhawa Simrat EVP, Head of R&D Sale 10b5-1 −33,830 $81.48 $2.8M 0

Page 3 of 6 · 119 trades